Klonopin Tablet
NDC Package 61269-620-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Klonopin (clonazepam) tablets is clonazepam is used to prevent and control seizures. This formulation utilizes a tablet delivery system. Marketed by H2-pharma, Llc, this product is identified by NDC 61269-620 and is authorized under FDA application NDA017533.

Identification & Billing

NDC Package Code
61269-620-10
Package Description
100 TABLET in 1 BOTTLE, PLASTIC
Product Code
61269-620
11-Digit Billing Format
61269062010
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Klonopin
Non-Proprietary Name
Clonazepam
Substance Name
Clonazepam
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
CLONAZEPAM 2 mg/1
Pharmacologic Class
Usage Information
Clonazepam is used to prevent and control seizures. This medication is known as an anticonvulsant or antiepileptic drug. It is also used to treat panic attacks. Clonazepam works by calming your brain and nerves. It belongs to a class of drugs called benzodiazepines.
DEA Schedule
Schedule IV (CIV) Substances

Regulatory & Marketing

Labeler Name
H2-pharma, Llc
Product Type
Human Prescription Drug
FDA Application #
NDA017533
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
06-02-1975
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 61269-620-10 identifies a specific commercial package of 100 tablet in 1 bottle, plastic of Klonopin, a human prescription drug labeled by H2-pharma, Llc. This tablet is formulated for oral use and contains clonazepam as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by H2-pharma, Llc on June 02, 1975. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

Clonazepam is used to prevent and control seizures. This medication is known as an anticonvulsant or antiepileptic drug. It is also used to treat panic attacks. Clonazepam works by calming your brain and nerves. It belongs to a class of drugs called benzodiazepines.

How is this H2-pharma, Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 61269062010. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
61269-620-10
11-Digit CMS (5-4-2)
61269-0620-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.